| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/19/2004 | WO2004014316A2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 02/19/2004 | WO2004014313A2 Combination pharmaceutical agents as inhibitors of hcv replication |
| 02/19/2004 | WO2004014309A2 Improved process for hydroxyazapirones |
| 02/19/2004 | WO2004014308A2 Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure |
| 02/19/2004 | WO2004014307A2 Gal3 antagonists for the treatment of neuropathic pain |
| 02/19/2004 | WO2004014306A2 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 02/19/2004 | WO2004014305A2 Method and compositions for inducing production of fibrous organic tissue |
| 02/19/2004 | WO2004014304A2 Electrospun amorphous pharmaceutical compositions |
| 02/19/2004 | WO2004014303A2 Method of applying hyaluronic acid to implant or graft to enhance lubricity and cellular density |
| 02/19/2004 | WO2004014300A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014295A2 Tiacumicin production |
| 02/19/2004 | WO2004014291A2 Use of methylnaltrexone in treating gastrointestinal dysfunction in equines |
| 02/19/2004 | WO2004014290A2 R-bambuterol, its preparation and therapeutic uses |
| 02/19/2004 | WO2004014289A2 Use of beta-cyclodextrin (cas rn: 7585-39-9) in the preparation of medicaments for the treatment of human and animal diseases caused by cryptosporidium parasites |
| 02/19/2004 | WO2004014271A1 Protection of the female reproductive system from natural and artificial insults |
| 02/19/2004 | WO2004014222A2 Diagnosis and treatment of tuberous sclerosis |
| 02/19/2004 | WO2004014159A1 Method of lowering glycaemic index of foods |
| 02/19/2004 | WO2004014151A1 Cereal based food product comprising dha and/or epa |
| 02/19/2004 | WO2004014147A1 Method for controlling hairballs |
| 02/19/2004 | WO2004007481A3 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 02/19/2004 | WO2004007478A3 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 02/19/2004 | WO2004007430A3 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 02/19/2004 | WO2004006886A3 Injectable depot formulation comprising crystals of iloperidone |
| 02/19/2004 | WO2004002463A3 Method of promoting smoking cessation |
| 02/19/2004 | WO2004000840A3 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 02/19/2004 | WO2004000793A3 Aminoacetonitrile derivatives suitable for controlling parasites |
| 02/19/2004 | WO2004000312A3 Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins |
| 02/19/2004 | WO2003105826A3 "soluble stable pharmaceutical composition for the administration of hiv protease inhibitors and a process for the preparation of concentrated pharmaceutical compositions for the administration of hiv protease inhibitors." |
| 02/19/2004 | WO2003104473A3 Galactosyl isomalt, method for production and use thereof |
| 02/19/2004 | WO2003101995A3 Camptothecins with a modified lactone ring |
| 02/19/2004 | WO2003099212A3 Mitogen activated protein kinase inhibitor compositions for lymphoma therapy |
| 02/19/2004 | WO2003096997A8 Reduction of hair growth |
| 02/19/2004 | WO2003092596A3 TREATING ECZEMA WITH A COMBINATION OF ISOTONIC SALINE OCEANè AND MAST CELL STABILIZERS |
| 02/19/2004 | WO2003089423A3 Novel flavanoids and chalcones as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 02/19/2004 | WO2003088979A3 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof |
| 02/19/2004 | WO2003086306A3 5ht2c receptor modulators |
| 02/19/2004 | WO2003082190A3 Spirocyclic amides as cannabinoid receptor modulators |
| 02/19/2004 | WO2003080640B1 Lymphatic and blood endothelial cell genes |
| 02/19/2004 | WO2003080036A3 Use of a vanilloid as an anti-snoring element |
| 02/19/2004 | WO2003078658A3 Methods for diagnosing and treating schizophrenia |
| 02/19/2004 | WO2003078574A3 Novel metabolic targets and markers |
| 02/19/2004 | WO2003077835A3 Sodium dodecyl sulfate compositions for inactivating prions |
| 02/19/2004 | WO2003075850A9 Methods for alzheimer's disease treatment and cognitive enhancement |
| 02/19/2004 | WO2003070745B1 Carbonate and carbamate modified forms of glucocorticoids |
| 02/19/2004 | WO2003070188A3 Method of treating trx mediated diseases |
| 02/19/2004 | WO2003065989A3 (oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 02/19/2004 | WO2003065988A3 A combination for treating cold and cough |
| 02/19/2004 | WO2003065975A3 Processes for preparing crystalline and amorphous mupirocin calcium |
| 02/19/2004 | WO2003065046A3 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor |
| 02/19/2004 | WO2003063793B1 Fatty acid-containing compositions and methods for the treatment of cytokine mediated disorders |
| 02/19/2004 | WO2003059255A3 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/19/2004 | WO2003049593A3 Prevention of flap necrosis in plastic surgery |
| 02/19/2004 | WO2003045411A3 Ginger extract preparation |
| 02/19/2004 | WO2003045398A8 Methods of making and pharmaceutical formulations comprising 7alpha, 11beta-dimethy-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 02/19/2004 | WO2003045359B1 Combination of cimetidine and cysteine derivatives for treating cancer |
| 02/19/2004 | WO2003043639A3 PHARMACEUTICAL COMPOSITION COMPRISING A ClC-2 CHANNEL OPENER |
| 02/19/2004 | WO2003043615A3 Hypertonia treatment during the acute phase of a cerebrovascular accident |
| 02/19/2004 | WO2003043576A3 Flowable osteogenic and chondrogenic compositions |
| 02/19/2004 | WO2003037265A9 Method of treating viral infections |
| 02/19/2004 | WO2003037168A3 Methods and formulations for minimizing spasticity in blood vessel grafts |
| 02/19/2004 | WO2003034028A3 Methods for identifying and using modulators of estrogen related receptor gamma |
| 02/19/2004 | WO2003031587A3 Use of stat-6 inhibitors as therapeutic agents |
| 02/19/2004 | WO2003030947A3 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 02/19/2004 | WO2003027234A9 Small organic molecule regulators of cell proliferation |
| 02/19/2004 | WO2003024402A3 Lpa receptor agonists and antagonists and methods of use |
| 02/19/2004 | WO2003024383B1 Methods and apparatus for improved administration of analgesics |
| 02/19/2004 | WO2003018770A3 Amplified oncogenes and their involvement in cancer |
| 02/19/2004 | WO2003014731A3 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/19/2004 | WO2002091989A3 Antiviral therapies using polyamine or polyamine analog-amino acid conjugates |
| 02/19/2004 | WO2002090514A8 Epidermal growth factor receptorantisense oligonucleotides |
| 02/19/2004 | WO2002087512A3 Once-a-day oxycodone formulations |
| 02/19/2004 | WO2002083866A3 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 02/19/2004 | WO2002081496A3 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 02/19/2004 | WO2002078736A3 Antiallergic pharmaceutical composition |
| 02/19/2004 | WO2002074290A3 Dermatological preparations containing a nsaid |
| 02/19/2004 | WO2002072086A3 Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases |
| 02/19/2004 | WO2002072067A3 Pharmaceutical aerosol formulation |
| 02/19/2004 | WO2002069884A3 A sunburn treatment and sunburn prevention method |
| 02/19/2004 | WO2002064214A8 Anti cancer combination of substituted pyrroles and paclitaxel |
| 02/19/2004 | WO2002064160A3 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 02/19/2004 | WO2002056895A3 Ionene polymers and their use in treating mucositis |
| 02/19/2004 | WO2002032920A3 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 02/19/2004 | WO2002032429A3 Use of inhibitors of progesterone receptor for treating cancer |
| 02/19/2004 | WO2002030356A3 Synthesis of epothilones and relates analogs |
| 02/19/2004 | WO2001040438A3 Methods and compositions for regulating lymphocyte activity |
| 02/19/2004 | WO2001020981A3 Anti-infective compositions for treating disordered tissue such as cold sores |
| 02/19/2004 | US20040034878 Using transgenic hypercellular nonhuman organisms as cell proliferating gene therapeutic tools |
| 02/19/2004 | US20040034336 Charged liposomes/micelles with encapsulted medical compounds |
| 02/19/2004 | US20040034242 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 02/19/2004 | US20040034241 Isolating policosanols from a seed or grain processing stream or a vegetable oil processing stream |
| 02/19/2004 | US20040034239 Inhibitors of nadh:ubiquinone oxidoreductase |
| 02/19/2004 | US20040034237 Materials and methods for the treatment of hypertension and angina |
| 02/19/2004 | US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin |
| 02/19/2004 | US20040034230 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent |
| 02/19/2004 | US20040034229 3,4-Di-substituted maleimide compounds as CXC chemokine receptor antagonists |
| 02/19/2004 | US20040034221 Enzyme inhibitors for treating AIDS |
| 02/19/2004 | US20040034219 Benzothiophene derivative compounds process of preparation and use thereof |
| 02/19/2004 | US20040034218 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 02/19/2004 | US20040034216 A gonane ring or with the nitrogen forming a heterocyclic structure; antiinflammation agents, antitumor agents; treating asthma, allergic disease, chronic obstructive pulmonary disease, atopic dermatitis, AIDS, arrhythmias |
| 02/19/2004 | US20040034209 Using genetic vaccine to treat and prevent infection by lymphadenopathy associated virus; viricides |